المؤلفون: Lin, Lishi, Soesan, Marcel, van Balen, Dorieke E M, Beijnen, Jos H, Huitema, Alwin D R

المساهمون: Apotheek O&O&O, Cancer

مصطلحات موضوعية: Body mass index, Breast cancer, Chemotherapy, Obesity, Paclitaxel, Relative dose intensity, Oncology, Cancer Research

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/448200Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/448200Test

المؤلفون: Leiah J. Brigitha, Rob Pieters, Inge M. van der Sluis

المصدر: European Journal of Cancer. 157:238-249

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Asparaginase, Time Factors, MEDLINE, Cumulative Exposure, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, Polyethylene Glycols, chemistry.chemical_compound, Risk groups, Pharmacokinetics, Internal medicine, medicine, Humans, Child, Childhood all, Randomized Controlled Trials as Topic, Dose-Response Relationship, Drug, business.industry, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dose intensity, Progression-Free Survival, chemistry, Lymphoblastic leukaemia, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e977d0315642b8c1b7ca177377485781Test
https://doi.org/10.1016/j.ejca.2021.08.025Test

المؤلفون: Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo’, Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, Adalgisa Condoluci

المصدر: Hematological oncologyREFERENCES. 40(5)

مصطلحات موضوعية: Cancer Research, Settore MED/15 - MALATTIE DEL SANGUE, Oncology, dose intensity, ibrutinib, chronic lymphocytic leukemia, Humans, Hematology, General Medicine, Leukemia, Lymphocytic, Chronic, B-Cell

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d5c2676c03db40dbc2bbe9f3ff09a4Test
https://pubmed.ncbi.nlm.nih.gov/35613703Test

المؤلفون: Yoo-Joung Ko, Winson Y. Cheung, Vincent C. Tam, Eugene Batuyong, Carla P Amaro, Richard M. Lee-Ying, Mohammed Abdulrahman Alghamdi, Jennifer J. Knox, Haider Samwi, Mina Swiha, Kelvin K. W. Chan, Hao-Wen Sim, Adriana Romagnino

المصدر: Cancer Medicine, Vol 9, Iss 14, Pp 4918-4928 (2020)
Cancer Medicine

مصطلحات موضوعية: 0301 basic medicine, Sorafenib, Male, Cancer Research, medicine.medical_specialty, Canada, Carcinoma, Hepatocellular, dose intensity, Antineoplastic Agents, Gastroenterology, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Clinical endpoint, Medicine, Humans, Radiology, Nuclear Medicine and imaging, In patient, Original Research, starting dose, business.industry, Proportional hazards model, discontinuation rate, Confounding, Liver Neoplasms, Clinical Cancer Research, hepatocellular carcinoma, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Dose intensity, digestive system diseases, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Propensity score matching, Female, sorafenib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052a2c3a401bfc76abd274010273d710Test
https://doaj.org/article/f30b00a8c00b40719fb7ffe444f5c912Test

المؤلفون: Kamel Laribi, Alix Baugier de Materre, Jonathan Farhi, Anne Besançon, Delphine Bolle, Mustafa Alani, Nathalie Denizon, Habib Ghnaya, Kayane Mheidly

المصدر: Cancer Medicine
Cancer Medicine, Vol 8, Iss 5, Pp 2188-2195 (2019)

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Antimetabolites, Antineoplastic, dose intensity, Population, Azacitidine, lcsh:RC254-282, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, myelodisplastic syndromes, Internal medicine, Retrospective analysis, Overall survival, Medicine, Humans, Radiology, Nuclear Medicine and imaging, education, Objective response, Original Research, Aged, Aged, 80 and over, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Myelodysplastic syndromes, Clinical Cancer Research, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Dose intensity, Survival Analysis, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Myelodysplastic Syndromes, Dose reduction, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a6addd0fa72cbccf5b4f2732b62f89Test
http://europepmc.org/articles/PMC6536936Test

المؤلفون: Ikuko Suzuki, Katsushi Tajima, Shuhei Okuyama, Hiroaki Kumagai, Masakazu Yamamoto, Eijiro Omoto, Kouji Saitou, Riko Tsumanuma, Shinji Satoh

المصدر: Journal of Cancer Research and Clinical Oncology. 146:2995-3002

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, animal structures, Multivariate analysis, Comorbidity, Gastroenterology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Cyclophosphamide, Aged, Aged, 80 and over, Hematology, Poor risk, business.industry, General Medicine, Middle Aged, medicine.disease, Dose intensity, Progression-Free Survival, nervous system diseases, Lymphoma, Treatment Outcome, 030104 developmental biology, Oncology, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Charlson comorbidity index, Prednisone, Female, Lymphoma, Large B-Cell, Diffuse, Rituximab, business, Diffuse large B-cell lymphoma, psychological phenomena and processes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37364fce40445a19d50d1ff8cfcc67d3Test
https://doi.org/10.1007/s00432-020-03279-7Test

المؤلفون: Debdeep Dey, Neeraj Arora, Saurabh Bhave, Jeevan Kumar, Vivek S. Radhakrishnan, Rimpa Basu Achari, Payal Mandal, Mammen Chandy, Chandrayee Sarker, Indu Arun, Reena Nair, Deepak Mishra, Zameer Latif

المصدر: ecancermedicalscience

مصطلحات موضوعية: anthracyclines, Cancer Research, medicine.medical_specialty, Anthracycline, business.industry, dose intensity, diffuse large B-cell lymphoma, Disease, medicine.disease, elderly, Lymphoma, International Prognostic Index, rituximab, Oncology, Internal medicine, Cohort, medicine, Clinical Study, Rituximab, Progression-free survival, business, Diffuse large B-cell lymphoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b504d442db9b9e0aafb1b65b624ed8a9Test
http://europepmc.org/articles/PMC8241458Test

المؤلفون: Ramy Sedhom, Arjun Gupta, Thomas J. Smith, Lindsey MacNabb

المصدر: Oncologist

مصطلحات موضوعية: Terminal Care, Cancer Research, medicine.medical_specialty, Palliative care, business.industry, Palliative Care, MEDLINE, Cancer, medicine.disease, Dose intensity, 03 medical and health sciences, 0302 clinical medicine, Oncology, Neoplasms, Commentaries, 030220 oncology & carcinogenesis, medicine, Humans, 030212 general & internal medicine, Intensive care medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d935f02642af50e75451cba4ebe3219Test
https://doi.org/10.1634/theoncologist.2020-0551Test

المؤلفون: Fumiyasu Nakamura, Hiroshi Seno, Soichi Arasawa, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Yuji Eso, Shigeharu Nakano, Eriko Iguchi, Masako Mishima, Kojiro Taura

المصدر: Cancers, Vol 12, Iss 1, p 49 (2019)
Cancers
Volume 12
Issue 1

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Multivariate analysis, dose intensity, relative dose intensity, lenvatinib, lcsh:RC254-282, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Treatment intensity, medicine, Body surface area, Receiver operating characteristic, business.industry, body surface area, molecular-targeted therapy, hepatocellular carcinoma, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Dose intensity, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 030211 gastroenterology & hepatology, albi grade, Lenvatinib, business, After treatment

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683791e1ec12b50275e129c965243f9bTest
https://www.mdpi.com/2072-6694/12/1/49Test

المؤلفون: Mayu Higuchi, Nobuyuki Enomoto, Yasuhiro Asahina, Namiki Izumi, Sakura Kirino, Shun Kaneko, Chiaki Maeyashiki, Wan Wang, Yuka Hayakawa, Nobuharu Tamaki, Shuhei Sekiguchi, Leona Osawa, Kaoru Tsuchiya, Yuka Takahashi, Koji Yamashita, Hiroyuki Nakanishi, Yutaka Yasui, Mao Okada, Jun Itakura, Kento Inada, Masayuki Kurosaki, Kenta Takaura

المصدر: Cancers, Vol 11, Iss 10, p 1517 (2019)
Cancers
Volume 11
Issue 10

مصطلحات موضوعية: Sorafenib, Cancer Research, medicine.medical_specialty, Gastroenterology, lcsh:RC254-282, Article, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Regorafenib, medicine, Objective response, sequential therapy, business.industry, Medical record, Disease progression, relative dose intensity (rdi), hepatocellular carcinoma, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Dose intensity, Oncology, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Total dose, 030211 gastroenterology & hepatology, sorafenib, regorafenib, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b880d6b1e1396f276af27c43bcc6ebfTest
https://www.mdpi.com/2072-6694/11/10/1517Test